The value of a general therapeutic approach in subjects with irritable bowel syndrome
Monsbakken, K. W., Vandvik, P. O., Farup, P. G.
Published in Alimentary pharmacology & therapeutics (01.01.2005)
Published in Alimentary pharmacology & therapeutics (01.01.2005)
Get full text
Journal Article
Mesalazine suppositories versus hydrocortisone foam in patients with distal ulcerative colitis. A comparison of the efficacy and practicality of two topical treatment regimens
Farup, P G, Hovde, O, Halvorsen, F A, Raknerud, N, Brodin, U
Published in Scandinavian journal of gastroenterology (1995)
Published in Scandinavian journal of gastroenterology (1995)
Get more information
Journal Article
Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance?
Lerang, F, Moum, B, Haug, J B, Tolås, P, Breder, O, Aubert, E, Høie, O, Søberg, T, Flaaten, B, Farup, P, Berge, T
Published in The American journal of gastroenterology (01.02.1997)
Get more information
Published in The American journal of gastroenterology (01.02.1997)
Journal Article
Mesalazine 4 g daily given as prolonged‐release granules twice daily and four times daily is at least as effective as prolonged‐release tablets four times daily in patients with ulcerative colitis
Farup, Per G., Hinterleitner, Thomas A., Lukáš, Milan, Hébuterne, Xavier, Rachmilewitz, Daniel, Campieri, Massimo, Meier, Rémy, Keller, Ralf, Rathbone, Barrie, Oddsson, Einar
Published in Inflammatory bowel diseases (01.08.2001)
Published in Inflammatory bowel diseases (01.08.2001)
Get full text
Journal Article